|   | [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|----------------------------------------------------------------------------------------------|

|   |  [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934  |
|--------|----------------------------------------------------------------------------------------------------------------------|

| Delaware                                                       | 06-1150326                        |
|----------------------------------------------------------------|-----------------------------------|
|                                                           |                              |
| (State or other jurisdiction of incorporation or organization) | (IRS employer identification no.) |
|                                                           |                              |

| Two Manhattanville Road                  |       |
|------------------------------------------|------------|
|                                     |       |
| Purchase, NY                             | 10577      |
|                                     |       |
| (Address of principal executive offices) | (Zip code) |

| Large Accelerated filer   ̈ | Accelerated Filer  x              |
|-------------------------------------------|---------------------------------------------|
|                                      |                                        |
| Non-Accelerated filer   ̈   | Smaller Reporting Company   ̈ |
|                                      |                                        |

----

|                                                                                                                   |     |                                                                                                              | Page   |
|------------------------------------------------------------------------------------------------------------------------|----------|-------------------------------------------------------------------------------------------------------------------|--------|
| PART I.                                                                                                                |     | FINANCIAL INFORMATION                                                                                             |   |
|                                                                                                                   |     |                                                                                                              |   |
| Item 1.                                                                                                                |     | Financial Statements                                                                                              |   |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     | Consolidated Balance Sheets at March 31, 2011 (unaudited) and December 31, 2010                                   | 3      |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     | Consolidated Statements of Operations for the three-month periods ended March 31, 2011 and 2010 (unaudited)       | 4      |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     | Consolidated Statements of Shareholders’ Equity for the three-month period ended March 31, 2011 (unaudited) | 5      |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     | Consolidated Statements of Cash Flows for the three-month periods ended March 31, 2011 and 2010 (unaudited)       | 6      |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     | Notes to Consolidated Financial Statements                                                                        | 7-13   |
|                                                                                                                   |     |                                                                                                              |   |
|                                                                                                                   |     |                                                                                                              |   |
| Item 2.                                                                                                                |     | Management’s Discussion and Analysis of Financial Condition and Results of Operations                       | 14-22  |
|                                                                                                                   |     |                                                                                                              |   |
| Item 3.                                                                                                                |     | Quantitative and Qualitative Disclosures About Market Risk                                                        | 23     |
|                                                                                                                   |     |                                                                                                              |   |
| Item 4.                                                                                                                |     | Controls and Procedures                                                                                           | 23     |
|                                                                                                                   |     |                                                                                                              |   |
| PART II.                                                                                                               |     | OTHER INFORMATION                                                                                                 |   |
|                                                                                                                   |     |                                                                                                              |   |
| Item 1.                                                                                                                |     | Legal Proceedings                                                                                                 | 24     |
|                                                                                                                   |     |                                                                                                              |   |
| Item 1A.                                                                                                               |     | Risk Factors                                                                                                      | 24     |
|                                                                                                                   |     |                                                                                                              |   |
| Item 2.                                                                                                                |     | Unregistered Sales of Equity Securities and Use of Proceeds                                                       | 24     |
|                                                                                                                   |     |                                                                                                              |   |
| Item 3.                                                                                                                |     | Defaults Upon Senior Securities                                                                                   | 24     |
|                                                                                                                   |     |                                                                                                              |   |
| Item 4.                                                                                                                |     | (Removed and Reserved)                                                                                            | 24     |
|                                                                                                                   |     |                                                                                                              |   |
| Item 5.                                                                                                                |     | Other Information                                                                                                 | 24     |
|  Item 6.                                                                                                          |     |  Exhibits                                                                                                    | 24     |
|                                                                                                                   |     |                                                                                                              |   |
| SIGNATURES                                                                                                             | 25       |
|                                                                                                                   |     |                                                                                                              |   |
| CERTIFICATIONS PURSUANT TO RULE 13A-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002        | EXHIBITS |
|                                                                                                                   |     |                                                                                                              |   |
| CERTIFICATIONS PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 | EXHIBITS |

----

|                                                                                                                                                                                                                                                                                                      | March 31, |          | December 31, |    |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|---------------|--------------|---------|
|                                                                                                                                                                                                                                                                                                      |      | 2011          |         |    | 2010 |   |
|                                                                                                                                                                                                                                                                                                      |      | (unaudited)   |         |    |   |   |
| ASSETS                                                                                                                                                                                                                                                                                                    |      |          |         |    |   |   |
| Current Assets:                                                                                                                                                                                                                                                                                           |      |          |         |    |   |   |
| Cash and cash equivalents                                                                                                                                                                                                                                                                                 | $         | 45,474        |         | $       | 50,183 |   |
| Patient and other receivables, net                                                                                                                                                                                                                                                                        |      | 8,172         |         |    | 7,350 |   |
| Deferred taxes                                                                                                                                                                                                                                                                                            |      | 2,480         |         |    | 2,510 |   |
| Other current assets                                                                                                                                                                                                                                                                                      |      | 11,048        |         |    | 9,611 |   |
| Total current assets                                                                                                                                                                                                                                                                                      |      | 67,174        |         |    | 69,654 |   |
|                                                                                                                                                                                                                                                                                                      |      |          |         |    |   |   |
| Fixed assets, net                                                                                                                                                                                                                                                                                         |      | 21,828        |         |    | 19,264 |   |
| Intangible assets, Business Service Rights, net                                                                                                                                                                                                                                                           |      | 24,968        |         |    | 22,915 |   |
| Goodwill                                                                                                                                                                                                                                                                                                  |      | 30,334        |         |    | 30,334 |   |
| Trademarks                                                                                                                                                                                                                                                                                                |      | 4,442         |         |    | 4,442 |   |
| Other assets                                                                                                                                                                                                                                                                                              |      | 2,142         |         |    | 2,046 |   |
| Total assets                                                                                                                                                                                                                                                                                              |  $   |  150,888 |         |  $ |  148,655 |   |
|                                                                                                                                                                                                                                                                                                      |      |          |         |    |   |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                                                                                                                                                                |      |          |         |    |   |   |
| Current liabilities:                                                                                                                                                                                                                                                                                      |      |          |         |    |   |   |
| Accounts payable                                                                                                                                                                                                                                                                                          | $         | 2,445         |         | $       | 3,626 |   |
| Accrued liabilities                                                                                                                                                                                                                                                                                       |      | 19,026        |         |    | 17,265 |   |
| Current portion of long-term notes payable and other obligations                                                                                                                                                                                                                                          |      | 3,781         |         |    | 3,784 |   |
| Due to Fertility Medical Practices                                                                                                                                                                                                                                                                        |      | 11,352        |         |    | 11,246 |   |
| Attain IVF deferred revenue and other patient deposits                                                                                                                                                                                                                                                    |      | 17,132        |         |    | 15,852 |   |
| Total current liabilities                                                                                                                                                                                                                                                                                 |      | 53,736        |         |    | 51,773 |   |
|                                                                                                                                                                                                                                                                                                      |      |          |         |    |   |   |
| Deferred and other tax liabilities                                                                                                                                                                                                                                                                        |      | 2,530         |         |    | 2,454 |   |
| Long-term notes payable and other obligations                                                                                                                                                                                                                                                             |      | 9,974         |         |    | 10,908 |   |
| Total liabilities                                                                                                                                                                                                                                                                                         |      | 66,240        |         |    | 65,135 |   |
|                                                                                                                                                                                                                                                                                                      |      |          |         |    |   |   |
| Commitments and Contingencies                                                                                                                                                                                                                                                                             |      |          |         |    |   |   |
|                                                                                                                                                                                                                                                                                                      |      |          |         |    |   |   |
| Shareholders’ equity:                                                                                                                                                                                                                                                                               |      |          |         |    |   |   |
| Common Stock, $.01 par value – 20,000,000 shares authorized at March 31, 2011 and at December 31, 2010,  11,860,169 and 11,735,339 issued at March 31, 2011 and December 31, 2010, and 11,822,961 and 11,728,491 shares outstanding at March 31, 2011 and December 31, 2010, respectively |      | 119           |         |    | 117 |   |
| Capital in excess of par                                                                                                                                                                                                                                                                                  |      | 76,904        |         |    | 76,483 |   |
| Other comprehensive loss                                                                                                                                                                                                                                                                                  |      | (42)          |         |    | (55 | ) |
| Treasury stock, at cost – 37,208 and 6,848 shares at March 31, 2011 and December 31, 2010 respectively                                                                                                                                                                                              |      | (330)         |         |    | (64 | ) |
| Retained earnings                                                                                                                                                                                                                                                                                         |      | 7,997         |         |    | 7,039 |   |
| Total shareholders’ equity                                                                                                                                                                                                                                                                          |      | 84,648        |         |    | 83,520 |   |
| Total liabilities and shareholders’ equity                                                                                                                                                                                                                                                          |  $   |  150,888 |         |  $ |  148,655 |   |

----

|                                                     |   | For theThree-month periodended March 31, |   |   |   |
|----------------------------------------------------------|--------|------------------------------------------|--------|--------|--------|
|                                                     |   | 2011                                     |   |   | 2010   |   |   |   |
| Revenues, net                                            |   |                                     |   |   |   |   |   |   |
| Attain Fertility Centers                                 |   | $                                        | 48,599 |   |   |  44,043 |   |
| Vein Clinics                                             |   |                                     | 15,660 |   |   |   | 12,981 |   |   |   |
|  Total revenues                                     |   |                                     | 64,259 |   |   |   | 57,024 |   |   |   |
|                                                     |   |                                     |   |   |   |   |   |   |   |   |
| Costs of services and sales                              |   |                                     |   |   |   |   |   |   |   |   |
| Attain Fertility Centers                                 |   |                                     | 44,164 |   |   |   | 39,598 |   |   |   |
| Vein Clinics                                             |   |                                     | 15,412 |   |   |   | 12,114 |   |   |   |
| Total costs of services and sales                        |   |                                     | 59,576 |   |   |   | 51,712 |   |   |   |
|                                                     |   |                                     |   |   |   |   |   |   |   |   |
| Contribution                                             |   |                                     |   |   |   |   |   |   |   |   |
| Attain Fertility Centers                                 |   |                                     | 4,435  |   |   |   | 4,445 |   |   |   |
| Vein Clinics                                             |   |                                     | 248    |   |   |   | 867 |   |   |   |
| Total contribution                                       |   |                                     | 4,683  |   |   |   | 5,312 |   |   |   |
|                                                     |   |                                     |   |   |   |   |   |   |   |   |
| General and administrative expenses                      |   |                                     | 3,041  |   |   |   | 3,196 |   |   |   |
| Interest income                                          |   |                                     | (48    | )      |   |   | (73) |   |   |   |
| Interest expense                                         |   |                                     | 142    |   |   |   | 277 |   |   |   |
| Total other expenses, net                                |   |                                     | 3,135  |   |   |   | 3,400 |   |   |   |
|                                                     |   |                                     |   |   |   |   |   |   |   |   |
| Income before income taxes                               |   |                                     | 1,548  |   |   |   | 1,912 |   |   |   |
| Income tax provision                                     |   |                                     | 590    |   |   |   | 791 |   |   |   |
| Net income                                               |   | $                                        | 958    |   |   | $ | 1,121 |   |   |   |
|                                                     |   |                                     |   |   |   |   |   |   |   |   |
| Basic and diluted net earnings per share of Common Stock |   |                                     |   |   |   |   |   |   |   |   |
| Basic earnings per share                                 |   | $                                        | 0.08   |   |   | $ | 0.11 |   |   |   |
| Diluted earnings per share                               |   | $                                        | 0.08   |   |   | $ | 0.11 |   |   |   |
|                                                     |   |                                     |   |   |   |   |   |   |   |   |
| Weighted average shares – basic                    |   |                                     | 11,813 |   |   |   | 10,217 |   |   |   |
| Weighted average shares - diluted                        |   |                                     | 11,867 |   |   |   | 10,269 |   |   |   |

----

|                                                         |   | Common Stock |    |   |   |   |    |                    |   |   | Treasury Shares                         |   |   |   |    |   |   |   |
|--------------------------------------------------------------|--------|--------------|---------|--------|--------|--------|---------|-------------------------|--------|--------|-----------------------------------------|--------|--------|--------|---------|--------|--------|--------|
|                                                         |   | Shares       |    |   | Amount |   |    | Capital inExcess of Par |   |   | Accumulated Comprehensive Income (loss) |   |   | Shares |    |   | Amount |   |   | Retained Earnings |   |   | Total Equity |   |
| Balance at December 31, 2010                                 |   |         | 11,735  |   |   | $      | 117     |                    |   | $      | 76,483                                  |   |   | $      | (55     | )      |   |   | (7 | ) |   | $ | (64 | ) |   | $ | 7,039 |   |   | $ | 83,520 |   |
| Stock awards granted, net                                    |   |         | 110     |   |   |   | 1       |                    |   |   | (1                                      | )      |   |   | — |   |   |   | (30 | ) |   |   | (266 | ) |   |   | — |   |   |   | (266 | ) |
| Restricted stock award and stock option expense amortization |   |         | — |   |   |   | — |                    |   |   | 353                                     |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 353 |   |
| Stock options exercised                                      |   |         | 15      |   |   |   | 1       |                    |   |   | 39                                      |   |   |   | (7      | )      |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 33 |   |
| Unrealized gain on hedging transaction, net                  |   |         | — |   |   |   | — |                    |   |   | —                                 |   |   |   | 20      |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 20 |   |
| Tax effect of equity transactions                            |   |         | — |   |   |   | — |                    |   |   | 30                                      |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 30 |   |
| Net income for the three months endedMarch 31, 2011          |   |         | — |   |   |   | — |                    |   |   | —                                 |   |   |   | — |   |   |   | — |   |   |   | — |   |   |   | 958 |   |   |   | 958 |   |
|  Balance at March 31, 2011                              |   |         | 11,860  |   |   | $      | 119     |                    |   | $      | 76,904                                  |   |   | $      | (42     | )      |   |   | (37 | ) |   | $ | (330 | ) |   | $ | 7,997 |   |   | $ | 84,648 |   |

----

|                                                                                         |   | For theThree-month periodended March 31, |    |
|----------------------------------------------------------------------------------------------|--------|------------------------------------------|---------|
|                                                                                         |   | 2011                                     |    |   | 2010 |   |
|                                                                                         |   |                                     |    |   |   |   |
| Cash flows from operating activities                                                         |   |                                     |    |   |   |   |
| Net income                                                                                   |   | $                                        | 958     |   |   | $ | 1,121 |   |
| Adjustments to reconcile net income to net cash provided by  operating activities: |   |                                     |    |   |   |   |   |   |
| Depreciation and amortization                                                                |   |                                     | 1,910   |   |   |   | 1,676 |   |
| Deferred income tax provision                                                                |   |                                     | 126     |   |   |   | 28 |   |
| Stock-based compensation                                                                     |   |                                     | 353     |   |   |   | 366 |   |
| Changes in assets and liabilities —                                                    |   |                                     |    |   |   |   |   |   |
| Decrease (increase) in assets                                                                |   |                                     |    |   |   |   |   |   |
| Patient and other accounts receivable                                                        |   |                                     | (822    | ) |   |   | (483 | ) |
| Other current assets                                                                         |   |                                     | (1,437  | ) |   |   | (2,869 | ) |
| Other assets                                                                                 |   |                                     | (96     | ) |   |   | 196 |   |
| (Decrease) increase in liabilities                                                           |   |                                     |    |   |   |   |   |   |
| Accounts payable                                                                             |   |                                     | (1,181  | ) |   |   | (410 | ) |
| Accrued liabilities                                                                          |   |                                     | 1,499   |   |   |   | (389 | ) |
| Due to fertility medical practices                                                           |   |                                     | 106     |   |   |   | 952 |   |
| Attain IVF Deferred revenue and other patient deposits                                       |   |                                     | 1,280   |   |   |   | 1,166 |   |
| Net cash provided by operating activities                                                    |   |                                     | 2,696   |   |   |   | 1,354 |   |
|                                                                                         |   |                                     |    |   |   |   |   |   |
| Cash flows from investing activities:                                                        |   |                                     |    |   |   |   |   |   |
| Purchase of business service rights                                                          |   |                                     | (2,377  | ) |   |   | — |   |
| Purchase of fixed assets, net                                                                |   |                                     | (4,150  | ) |   |   | (1,770 | ) |
| Net cash used in investing activities                                                        |   |                                     | (6,527  | ) |   |   | (1,770 | ) |
|                                                                                         |   |                                     |    |   |   |   |   |   |
| Cash flows from financing activities:                                                        |   |                                     |    |   |   |   |   |   |
| Debt repayments                                                                              |   |                                     | (917    | ) |   |   | (915 | ) |
| Common Stock transactions, net                                                               |   |                                     | — |   |   |   | 19,064 |   |
| Proceeds from stock option exercises                                                         |   |                                     | 39      |   |   |   | 24 |   |
| Net cash provided by (used in) financing activities                                          |   |                                     | (878    | ) |   |   | 18,173 |   |
|                                                                                         |   |                                     |    |   |   |   |   |   |
| Net increase (decrease) in cash and cash equivalents                                         |   |                                     | (4,709  | ) |   |   | 17,757 |   |
| Cash and cash equivalents at beginning of period                                             |   |                                     | 50,183  |   |   |   | 28,865 |   |
| Cash and cash equivalents at end of period                                                   |   | $                                        | 45,474  |   |   | $ | 46,622 |   |
|                                                                                         |   |                                     |    |   |   |   |   |   |
| Supplemental Information:                                                                    |   |                                     |    |   |   |   |   |   |
| Interest paid                                                                                |   |                                     | 148     |   |   |   | 321 |   |
| Income taxes paid                                                                            |   |                                     | 81      |   |   |   | 362 |   |

----

|                                                                   |   | For the three-month periodended March 31, |   |
|------------------------------------------------------------------------|--------|-------------------------------------------|--------|
|                                                                   |   | 2011                                      |   |   | 2010 |   |
| Numerator                                                              |   |                                      |   |   |   |   |
| Net Income                                                             |   | $                                         | 958    |   |   | $ | 1,121 |   |
|                                                                   |   |                                      |   |   |   |   |   |   |
| Denominator                                                            |   |                                      |   |   |   |   |   |   |
| Weighted average shares outstanding (basic)                            |   |                                      | 11,813 |   |   |   | 10,217 |   |
| Effect of dilutive options and warrants                                |   |                                      | 54     |   |   |   | 52 |   |
| Weighted average shares and dilutive potential Common shares (diluted) |   |                                      | 11,867 |   |   |   | 10,269 |   |
|                                                                   |   |                                      |   |   |   |   |   |   |
| Basic earnings per share                                               |   | $                                         | 0.08   |   |   | $ | 0.11 |   |
| Diluted earnings per share                                             |   | $                                         | 0.08   |   |   | $ | 0.11 |   |

----

|                                      |   | Attain Fertility Centers |    |   | VeinClinics |   |    | Corp G&A |   |   | Consolidated |   |
|-------------------------------------------|--------|--------------------------|---------|--------|-------------|--------|---------|--------------|--------|--------|--------------|--------|
|                                      |   |                     |    |   |        |   |    |         |   |   |         |   |
| For the three months ended March 31, 2011 |   |                     |    |   |        |   |    |         |   |   |         |   |
| Total Revenues, net                       |   | $                        | 48,599  |   |        | $      | 15,660  |         |   | $      | —      |   |   | $ | 64,259 |   |
| Cost of Services and Sales                |   |                     | 44,164  |   |        |   | 15,412  |         |   |   | —      |   |   |   | 59,576 |   |
| Contribution                              |   |                     | 4,435   |   |        |   | 248     |         |   |   | —      |   |   |   | 4,683 |   |
| Operating margin                          |   |                     | 9.1     | %      |        |   | 1.6     | %            |   |   | 0.0          | %      |   |   | 7.3 | % |
|                                      |   |                     |    |   |        |   |    |         |   |   |         |   |   |   |   |   |
| General and Administrative                |   |                     | — |   |        |   | — |         |   |   | 3,041        |   |   |   | 3,041 |   |
| Interest (income) expense                 |   |                     | (32     | )      |        |   | — |         |   |   | 126          |   |   |   | 94 |   |
| Income before income taxes                |   | $                        | 4,467   |   |        | $      | 248     |         |   | $      | (3,167       | )      |   | $ | 1,548 |   |
|                                      |   |                     |    |   |        |   |    |         |   |   |         |   |   |   |   |   |
| Depreciation expense included above       |   | $                        | 974     |   |        | $      | 443     |         |   | $      | 169          |   |   | $ | 1,586 |   |
| Capital Expenditures                      |   | $                        | 1,430   |   |        | $      | 2,535   |         |   | $      | 185          |   |   | $ | 4,150 |   |
| Total Assets                              |   | $                        | 44,730  |   |        | $      | 56,917  |         |   | $      | 49,241       |   |   | $ | 150,888 |   |

| For the three months ended March 31, 2010 |   |   |    |   |   |   |    |   |   |   |    |   |
|-------------------------------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|---------|--------|
| Total Revenues, net                       |   | $      | 44,043  |   |   | $      | 12,981  |   |   | $      | — |   |   | $ | 57,024 |   |
| Cost of Services and Sales                |   |   | 39,598  |   |   |   | 12,114  |   |   |   | — |   |   |   | 51,712 |   |
| Contribution                              |   |   | 4,445   |   |   |   | 867     |   |   |   | — |   |   |   | 5,312 |   |
| Operating margin                          |   |   | 10.1    | %      |   |   | 6.7     | %      |   |   | 0.0     | %      |   |   | 9.3 | % |
|                                      |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
| General and Administrative                |   |   | — |   |   |   | — |   |   |   | 3,196   |   |   |   | 3,196 |   |
| Interest (income) expense                 |   |   | (73     | )      |   |   | — |   |   |   | 277     |   |   |   | 204 |   |
| Income before income taxes                |   | $      | 4,518   |   |   | $      | 867     |   |   | $      | (3,473  | )      |   | $ | 1,912 |   |
|                                      |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
| Depreciation expense included above       |   | $      | 961     |   |   | $      | 236     |   |   | $      | 173     |   |   | $ | 1,370 |   |
| Capital Expenditures                      |   | $      | 1,146   |   |   | $      | 547     |   |   | $      | 77      |   |   | $ | 1,770 |   |
| Total Assets                              |   | $      | 39,581  |   |   | $      | 52,731  |   |   | $      | 53,133  |   |   | $ | 145,445 |   |
|                                      |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |

----

|                                          | March 31,   |   | December 31, |   |
|-----------------------------------------------|-------------|--------|--------------|--------|
|                                          | 2011        |   | 2010         |   |
|                                          | (unaudited) |   |         |   |
| Vein Clinic patient and insurance receivables |        | $      | 10,097       |   |   | $ | 9,745 |   |
| Reserve for uncollectible accounts            |        |   | (2,249       | )      |   |   | (2,492 | ) |
| Subtotal Vein Clinic receivables, net         |        | $      | 7,848        |   |   | $ | 7,253 |   |
| Other receivables                             |        |   | 324          |   |   |   | 97 |   |
| Total Patient and other receivables, net      |        | $      | 8,172        |   |   | $ | 7,350 |   |

----

|                                    |  March 31, |   | December 31, |   |
|-----------------------------------------|-----------------|--------|--------------|--------|
|                                    | 2011            |   | 2010         |   |
|                                    | (unaudited)     |   |         |   |
| Advances to Partner fertility practices |            | $      | (17,760      | )      |   | $ | (14,906 | ) |
| Undistributed Physician Earnings        |            |   | 3,900        |   |   |   | 2,841 |   |
| Physician Practice Patient Deposits     |            |   | 25,212       |   |   |   | 23,311 |   |
| Due to Fertility Medical Practices, net |            | $      | 11,352       |   |   | $ | 11,246 |   |

|                                           |   | March 31,   |   |   | December 31, |   |
|------------------------------------------------|--------|-------------|--------|--------|--------------|--------|
|                                           |   | 2011        |   |   | 2010         |   |
|                                           |   | (unaudited) |   |   |         |   |
| Note payable to bank                           |   | $           | 13,583 |   |         | $      | 14,476 |   |
| Derivative fair valuation adjustment           |   |        | 66     |   |         |   | 87 |   |
| Obligations under capital leases               |   |        | 106    |   |         |   | 129 |   |
|                                           |   |        |   |   |         |   |   |   |
| Total notes payable and other obligations      |   | $           | 13,755 |   |         | $      | 14,692 |   |
|    Less — current portion |   |        | (3,781 | )      |         |   | (3,784 | ) |
|                                           |   |        |   |   |         |   |   |   |
| Long-term notes payable and other obligations  |   | $           | 9,974  |   |         | $      | 10,908 |   |

----

|                          |   | For the three-month periodended March 31, |    |
|-------------------------------|--------|-------------------------------------------|---------|
|                          |   | 2011                                      |    |   | 2010 |   |
|                          |   |                                      |    |   |   |   |   |   |
| Fair value of options granted |   | $                                         | — |   |   | $ | 5.13 |   |
| Dividend yield                |   |                                      | 0       | % |   |   | 0 | % |
| Expected volatility           |   |                                      | 0       | % |   |   | 58.2 | % |
| Risk free interest rate       |   |                                      | 0       | % |   |   | 4.0 | % |
| Expected term in years        |   |                                      | — |   |   |   | 5.0 |   |

|                                     |   | Number of shares of Common Stock underlying options |    |   | Weighted Average Exercise Price |
|------------------------------------------|--------|-----------------------------------------------------|---------|--------|---------------------------------|
|                                     |   |                                                |    |   |                            |   |   |   |
| Options outstanding at December 31, 2010 |   |                                                | 247,986 |   |                            | $ | 6.96 |   |
| Granted – stock options            |   |                                                | — |   |                            | $ | — |   |
| Granted – stock awards             |   |                                                | 109,595 |   |                            | $ | 8.76 |   |
| Exercised – stock options          |   |                                                | 15,235  |   |                            | $ | 2.63 |   |
| Exercised – stock awards           |   |                                                | 109,595 |   |                            | $ | 8.76 |   |
| Canceled                                 |   |                                                | 11,366  |   |                            | $ | 8.59 |   |
|                                     |   |                                                |    |   |                            |   |   |   |
| Options outstanding at March 31, 2011    |   |                                                | 221,385 |   |                            | $ | 7.17 |   |
|                                     |   |                                                |    |   |                            |   |   |   |
| Options exercisable at:                  |   |                                                |    |   |                            |   |   |   |
| December 31, 2010                        |   |                                                | 132,137 |   |                            | $ | 5.95 |   |
| March 31, 2011                           |   |                                                | 138,754 |   |                            | $ | 6.62 |   |

----

|                                          |   | For the three-month periodended March 31, |   |
|-----------------------------------------------|--------|-------------------------------------------|--------|
|                                          |   | 2011                                      |   |   | 2010 |   |
|                                          |   |                                      |   |   |   |   |   |   |
| Net income as reported                        |   | $                                         | 958    |   |   | $ | 1,121 |   |
| Unrealized gain (loss) on hedging transaction |   |                                      | 20     |   |   |   | 104 |   |
| Related Tax Benefit                           |   |                                      | (7     | ) |   |   | (40 | ) |
|                                          |   |                                      |   |   |   |   |   |   |
| Total comprehensive income                    |   | $                                         | 971    |   |   | $ | 1,185 |   |

----

----

|   | ITEM 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|--------|----------------------------------------------------------------------------------------------------------------|

|          |                                                                                                     |
|---------------|----------------------------------------------------------------------------------------------------------|
| •  | Drive growth at our contracted fertility centers by providing additional management; services.      |
|          |                                                                                                     |
| •  | Expand the relationships to additional fertility centers through the sale of consumer product offerings; |
|          |                                                                                                     |
| •  | Develop de novo vein clinics;                                                                            |
|          |                                                                                                     |
| •  | Increase the total number of patients treated;                                                           |
|          |                                                                                                     |
| •  | Increase the penetration of our Attain IVF programs; and                                            |
|          |                                                                                                     |
| •  | Continue to improve operating efficiencies.                                                              |

----

----

|                                |   | For the three-month periodended March 31, |   |
|-------------------------------------|--------|-------------------------------------------|--------|
|                                |   | 2011                                      |   |   | 2010 |   |
|                                |   |  (unaudited)                         |
| Revenues, Net                       |   |                                      |   |   |   |   |
| Attain Fertility Centers            |   |                                      | 75.6   | % |   |   | 77.2 | % |
| Vein Clinics                        |   |                                      | 24.4   | % |   |   | 22.8 | % |
| Total revenues                      |   |                                      | 100.0  | % |   |   | 100.0 | % |
|                                |   |                                      |   |   |   |   |   |   |
| Cost of services and sales          |   |                                      |   |   |   |   |   |   |
| Attain Fertility Centers            |   |                                      | 68.7   | % |   |   | 69.4 | % |
| Vein Clinics                        |   |                                      | 24.0   | % |   |   | 21.3 | % |
|                                |   |                                      | 92.7   | % |   |   | 90.7 | % |
|                                |   |                                      |   |   |   |   |   |   |
| Contribution                        |   |                                      |   |   |   |   |   |   |
| Attain Fertility Centers            |   |                                      | 6.9    | % |   |   | 7.8 | % |
| Vein Clinics                        |   |                                      | 0.4    | % |   |   | 1.5 | % |
|                                |   |                                      | 7.3    | % |   |   | 9.3 | % |
|                                |   |                                      |   |   |   |   |   |   |
| General and administrative expenses |   |                                      | 4.7    | % |   |   | 5.6 | % |
| Interest income                     |   |                                      | (0.1   | )% |   |   | (0.1 | )% |
| Interest expense                    |   |                                      | 0.2    | % |   |   | 0.4 | % |
| Total other expenses                |   |                                      | 4.9    | % |   |   | 5.9 | % |
|                                |   |                                      |   |   |   |   |   |   |
| Income before income taxes          |   |                                      | 2.4    | % |   |   | 3.4 | % |
| Income tax provision                |   |                                      | 0.9    | % |   |   | 1.4 | % |
| Net income                          |   |                                      | 1.5    | % |   |   | 2.0 | % |

----

|          |                                                                                                                                                                                                                                        |
|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| •  | A base service fee calculated as a percentage of patient revenues as reported by the Partner fertility center (this percentage generally varies from 6% down to 3% depending on the agreement and the level of patient revenues);           |
|          |                                                                                                                                                                                                                                        |
| •  | Cost of services equal to reimbursement for the expenses which we advance to the Partner fertility center during the month (representing substantially all of the expenses incurred by the center, except physician compensation); and |
|          |                                                                                                                                                                                                                                        |
| •  | Our additional fees which represent our share of the net income of the Partner fertility center (which varies from 10% to 20% or a fixed amount depending on the underlying center, subject to limits in some circumstances).               |

----

|                                                  |   | For the three-month periodended March 31, |   |
|-------------------------------------------------------|--------|-------------------------------------------|--------|
|                                                  |   | 2011                                      |   |   | 2010 |   |
|                                                  |   | (unaudited)                               |   |
|                                                  |   | Providers                                 |   |   | Providers |   |
| Partner Fertility Center Financials                   |   |                                      |   |   |   |   |
| (a) Patient revenue                                   |   | $                                         | 57,727 |   |   | $ | 51,959 |   |
| (b) Cost of services                                  |   |                                      | 37,220 |   |   |   | 34,095 |   |
| (c) Base service fee                                  |   |                                      | 2,898  |   |   |   | 2,682 |   |
| (d) Practice contribution (a-b-c)                     |   |                                      | 17,609 |   |   |   | 15,182 |   |
| (e) Physician compensation                            |   |                                      | 16,042 |   |   |   | 13,693 |   |
| (f) IntegraMed additional fee                         |   |                                      | 1,567  |   |   |   | 1,489 |   |
|                                                  |   |                                      |   |   |   |   |   |   |
| IntegraMed Financials                                 |   |                                      |   |   |   |   |   |   |
| (g) IntegraMed gross revenue (b+c+f)                  |   |                                      | 41,685 |   |   |   | 38,266 |   |
| (h) Amortization of business service rights           |   |                                      | (324   | ) |   |   | (324 | ) |
| (i) Other revenue                                     |   |                                      | 31     |   |   |   | 15 |   |
| (j) IntegraMed fertility services revenue (g+h+i)     |   | $                                         | 41,392 |   |   | $ | 37,957 |   |
| (k) Cost of Services                                  |   |                                      | 37,250 |   |   |   | 34,133 |   |
|       Division Overhead |   |                                      | 2,228  |   |   |   | 769 |   |
| (l) Contribution of IntegraMed Centers (j-k)          |   | $                                         | 1,914  |   |   | $ | 3,055 |   |

----

|                       |   | Period ended March 31, 2011 |    |
|----------------------------|--------|-----------------------------|---------|
|                       |   |                        | Q1 2011 |   |   |   | Q1 2010 |   |   | Change |   |   | % Change |   |
| Revenues, Net              |   | $                           | 48,599  |   |   | $ | 44,043 |   |   | $ | 4,556 |   |   |   | 10 | % |
| Contribution               |   | $                           | 4,435   |   |   | $ | 4,445 |   |   | $ | (10 | ) |   |   | (0.2 | %) |
|                       |   |                        |    |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Partner Center Statistics: |   |                        |    |   |   |   |   |   |   |   |   |   |   |   |   |   |
| New Patient Visits         |   |                        | 7,639   |   |   |   | 7,041 |   |   |   | 598 |   |   |   | 9 | % |
| IVF Cases Completed        |   |                        | 3,808   |   |   |   | 3,413 |   |   |   | 395 |   |   |   | 12 | % |
| IUI Cycles                 |   |                        | 6,017   |   |   |   | 5,723 |   |   |   | 294 |   |   |   | 5 | % |
| Attain IVF Statistics:     |   |                        |    |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Applications               |   |                        | 761     |   |   |   | 725 |   |   |   | 36 |   |   |   | 5 | % |
| Enrollments                |   |                        | 439     |   |   |   | 361 |   |   |   | 78 |   |   |   | 22 | % |
| Pregnancies                |   |                        | 267     |   |   |   | 216 |   |   |   | 51 |   |   |   | 24 | % |
|                       |   |                        |    |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                       |   |                        |    |   |   |   |   |   |   |   |   |   |   |   |   |   |

|          |                                                              |
|---------------|-------------------------------------------------------------------|
| •  | the number of patients enrolled and receiving treatment, and |
|          |                                                              |
| •  | clinical pregnancy rates.                                         |

----

|              |   | Period ended March 31, 2011 |    |
|-------------------|--------|-----------------------------|---------|
|              |   |                        | Q1 2011 |   |   |   | Q1 2010 |   |   | Change |   |   | % Change |   |
| Revenues, Net     |   | $                           | 15,660  |   |   | $ | 12,981 |   |   | $ | 2,679 |   |   |   | 21 | % |
| Contribution      |   | $                           | 248     |   |   | $ | 867 |   |   | $ | (619 | ) |   |   | (71 | %) |
| Inquiries         |   |                        | 5,733   |   |   |   | 5,244 |   |   |   | 489 |   |   |   | 9 | % |
| New Consultations |   |                        | 3,723   |   |   |   | 3,420 |   |   |   | 303 |   |   |   | 9 | % |
| First Leg Starts  |   |                        | 2,125   |   |   |   | 1,882 |   |   |   | 243 |   |   |   | 13 | % |
|              |

----

----

|                               |   | Payments Due by Period |         |
|------------------------------------|--------|------------------------|--------------|
|                               |   |                   |         |   | Less Than |   |   |   |   |   |   |   |   | After |   |
|                               |   | Total                  |         |   | 1 Year |   |   | 1 — 3 Years |   |   | 4 — 5 Years |   |   | 5 Years |   |
|                               |   | (in thousands)         |         |
|                               |   |                   |         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Notes payable                      |   | $                      | 13,583       |   |   | $ | 3,667 |   |   | $ | 9,916 |   |   | $ |   — |   |   | $ |     — |   |
| Capital lease obligations          |   |                   | 106          |   |   |   | 97 |   |   |   | 9 |   |   |   |     — |   |   |   |     — |   |
| Interest on debt                   |   |                   | 904          |   |   |   | 525 |   |   |   | 379 |   |   |   |     — |   |   |   |     — |   |
| Operating leases                   |   |                   | 74,825       |   |   |   | 8,050 |   |   |   | 31,493 |   |   |   | 7,538 |   |   |   | 27,744 |   |
|                               |   |                   |         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Total contractual cash obligations |   |   $               |  89,418 |   |   |  $ |  12,339 |   |   |  $ |  41,797 |   |   |  $ |  7,538 |   |   | $  |  27,744 |   |

|                   |   | Amount of Commitment Expiration Per Period |   |
|------------------------|--------|--------------------------------------------|--------|
|                   |   |                                       |   |   | Less Than |   |   |   |   |   |   |   |   | After |   |
|                   |   | Total                                      |   |   | 1 Year |   |   | 1 — 3 Years |   |   | 4 — 5 Years |   |   | 5 Years |   |
|                   |   | (in thousands)                             |   |
|                   |   |                                       |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Unused lines of credit |   | $                                          | 35,000 |   |   | $ |   — |   |   | $ | 35,000 |   |   | $ |     — |   |   | $ |     — |   |

|    |          |                                                                                                                         |
|--------------|---------------|------------------------------------------------------------------------------------------------------------------------------|
|         | •  | We provide a cash credit to the practice for billings to patients and insurance companies;                                   |
|         |          |                                                                                                                         |
|         | •  | We reduce the cash credit for center expenses that we have incurred on behalf of the practice;                               |
|         |          |                                                                                                                         |
|         | •  | We reduce the cash credit for the base portion of our service fee which relates to the Partner revenues;                     |
|         |          |                                                                                                                         |
|         | •  | We reduce the cash credit for the variable portion of our service fee which relates to the Partner earnings; and        |
|         |          |                                                                                                                         |
|         | •  | We disburse to the medical practice the remaining cash amount which represents the physician’s undistributed earnings. |

----

| (a)   | Evaluation of disclosure controls and procedures |
|-----------------|--------------------------------------------------|

----

|  Part II   |   |  OTHER INFORMATION                                                                                                                                                               |
|---------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                      |   |                                                                                                                                                                                  |
|                      |   |                                                                                                                                                                                  |
|  Item 1.        |   |  Legal Proceedings                                                                                                                                                               |
|                      |   |                                                                                                                                                                                  |
|                      |   | From time to time, we are party to legal proceedings in the ordinary course of business.  Please refer to Note 12 of these financial statements for additional disclosures. |
|                      |   |                                                                                                                                                                                  |
|   Item 1A.           |   |  Risk Factors                                                                                                                                                                    |
|                      |   |                                                                                                                                                                                  |
|                      |   | There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2010.                                |
|       |   |                                                                                                                                                                                  |
| Item 2.                   |   | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                           |
|                      |   |  None.                                                                                                                                                                           |
|                      |   |                                                                                                                                                                                  |
| Item 3.                   |   | Defaults upon Senior Securities                                                                                                                                                       |
|                      |   |                                                                                                                                                                                  |
|                      |   |  None.                                                                                                                                                                           |
|                      |   |                                                                                                                                                                                  |
| Item 4.                   |   | (Removed and Reserved)                                                                                                                                                                |   |
|                      |   |                                                                                                                                                                                  |   |
|                      |   |                                                                                                                                                                                  |   |
| Item 5.                   |   | Other Information                                                                                                                                                                     |   |
|                      |   |                                                                                                                                                                                  |   |
|                      |   | None.                                                                                                                                                                                 |   |
|                      |   |                                                                                                                                                                                  |   |
| Item 6.                   |   | Exhibits                                                                                                                                                                              |   |
|                      |   |                                                                                                                                                                                  |   |
|                      |   | See Index to Exhibits on Page 26.                                                                                                                                                     |   |
|                      |   |                                                                                                                                                                                  |   |

----

|       |              |   |   |                                                                                                                   |
|------------|-------------------|--------|--------|------------------------------------------------------------------------------------------------------------------------|
|  Date |  May 6, 2011 |   | By:    | INTEGRAMED AMERICA, INC.(Registrant)  /s/   Timothy P. Sheehan                                     |
|       |              |   |   | Timothy P. SheehanVice President Finance andInterim Chief Financial Officer(Principal Financial andAccounting Officer) |

----

| ExhibitNumber | Description                                                                                                                                |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------------|
|          |                                                                                                                                       |
|          |                                                                                                                                       |
|          |                                                                                                                                       |
| 31.1          | CEO Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated May 6, 2011        |
|          |                                                                                                                                       |
| 31.2          | CFO Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated May 6, 2011        |
|          |                                                                                                                                       |
| 32.1          | CEO Certification Pursuant to 18 U.S.C. § 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated May 6, 2011 |
|          |                                                                                                                                       |
| 32.2          | CFO Certification Pursuant to 18 U.S.C. § 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 dated May 6, 2011 |

----